Autologous Bone Marrow Transplant in Delhi

Autologous Bone Marrow Transplant (ABMT), also known as Autologous Stem Cell Transplant (ASCT), is a procedure in which a patient’s own stem cells are collected, stored, and reinfused after high-dose chemotherapy. It is commonly used for conditions such as multiple myeloma, Hodgkin lymphoma, and Non-Hodgkin lymphoma.

What Is an Autologous Bone Marrow Transplant?

Autologous Bone Marrow Transplant is a specialised treatment that allows doctors to safely administer high-dose chemotherapy while protecting the patient’s bone marrow. 

Before chemotherapy begins, healthy stem cells are collected from the patient and stored. After chemotherapy destroys cancer cells, the stored stem cells are infused back into the bloodstream to rebuild healthy blood and immune cells.

In simple terms, the process of autologous BMT can be understood in three stages:

• Collect healthy stem cells
• Administer high-dose chemotherapy
• Reinfuse stem cells to restore bone marrow function

Autologous BMT acts as a rescue treatment that helps the bone marrow recover after intensive chemotherapy.

Who Needs an Autologous Stem Cell Transplant?

Autologous stem cell transplant is recommended for certain cancers where the bone marrow itself remains healthy, but high-dose chemotherapy is needed to improve treatment outcomes.

Common Conditions for which autologous BMT is performed include:

• Multiple Myeloma

Multiple myeloma is the most common indication for autologous transplant worldwide. The procedure helps achieve deeper remission and improves long-term disease control.

•  Hodgkin Lymphoma

Patients with relapsed or refractory Hodgkin lymphoma may benefit from autologous transplant following successful salvage chemotherapy.

• Non-Hodgkin Lymphoma

Aggressive or relapsed Non-Hodgkin lymphoma that responds to second-line treatment may be consolidated with an autologous transplant.

• High-Risk Neuroblastoma

In children with high-risk neuroblastoma, autologous transplant forms an important part of standard treatment protocols.

• Relapsed Germ Cell Tumours

Selected patients with relapsed germ cell tumours may undergo high-dose chemotherapy followed by autologous stem cell rescue.

Autologous BMT is generally used when stronger chemotherapy is required but the patient’s own stem cells remain healthy enough to be reused.

Autologous vs Allogeneic Bone Marrow Transplant

Patients often ask how autologous transplant differs from donor-based transplantation.

While autologous transplant generally carries fewer complications, allogeneic transplant offers a beneficial graft-versus-cancer effect that may be important in certain diseases.

Autologous Bone Marrow Transplant Procedure

The autologous transplant process usually takes several weeks and involves six important stages.

Step 1: Pre-Transplant Evaluation

Before transplantation, doctors assess whether the patient is fit enough to tolerate high-dose chemotherapy.

Common investigations include:

• Blood tests
• Bone marrow examination
• PET-CT scan (when required)
• Heart function assessment
• Lung function testing
• Kidney and liver evaluation

This evaluation helps identify potential risks and ensures the safest possible treatment plan.

Step 2: Stem Cell Mobilisation

Normally, stem cells remain inside the bone marrow. To collect them, doctors first encourage these cells to move into the bloodstream.

Step 3: Stem Cell Collection (Apheresis)

Once sufficient stem cells are circulating in the blood, they are collected through a process known as apheresis.

During apheresis:

• Blood is withdrawn through a central line
• A machine separates stem cells
• Remaining blood is returned to the body
• The procedure usually lasts 4-6 hours

Most patients require one or two collection sessions. The stem cells are then frozen and safely stored until transplant day.

Step 4: High-Dose Chemotherapy

This is the most intensive phase of treatment. High-dose chemotherapy is administered to destroy as many remaining cancer cells as possible.

Step 5: Stem Cell Infusion

Following chemotherapy, the frozen stem cells are thawed and infused through a central venous catheter. The infusion does not require surgery and usually takes a few hours.

The infused stem cells naturally travel to the bone marrow and begin rebuilding blood production.

Step 6: Engraftment and Recovery

Engraftment occurs when transplanted stem cells begin producing healthy blood cells.

Most patients experience:

• White blood cell recovery within 10–14 days
• Platelet recovery shortly afterwards
• Gradual improvement in immune function

Patients remain under close observation until blood counts reach safe levels.

Recovery After Autologous Bone Marrow Transplant

Recovery continues well beyond hospital discharge and occurs in stages.

During Hospital Stay

Patients commonly experience:

• Fatigue
• Mouth ulcers (mucositis)
• Nausea
• Reduced appetite
• Low blood counts
• Increased infection risk

These side effects are primarily caused by chemotherapy rather than the stem cell infusion itself.

After Discharge

First Month

• Weekly follow-up visits
• Blood count monitoring
• Infection precautions

Months 2-3

• Energy levels gradually improve
• Appetite returns
• Physical activity increases

Months 3-6

• Most patients resume normal daily activities
• Many return to work or school

Months 6-12

• Continued immune system recovery
• Vaccination schedules may begin

Recovery is gradual, but most patients notice significant improvement within the first few months after transplant.

Autologous Bone Marrow Transplant Success Rate

Success rates depend on several factors, including diagnosis, disease stage, response to treatment, and overall health.

Multiple Myeloma Outcomes

Indian multicentre data has reported:

• 77% complete remission or better
• 91% one-year survival
• 85% two-year survival
• 72% five-year survival

Risks and Complications of Autologous Bone Marrow Transplant

Although autologous BMT is generally safer than donor transplants, complications can still occur.

Potential risks include:

• Serious infections
• Bleeding due to low platelet counts
• Mouth ulcers and mucositis
• Nausea and vomiting
• Organ toxicity from chemotherapy
• Delayed engraftment
• Disease relapse

Close monitoring by an experienced transplant team helps minimise these risks and ensures timely treatment if complications occur.

Autologous Bone Marrow Transplant Cost in Delhi

One of the most common questions patients ask is about the cost of autologous stem cell transplant in Delhi.

The approximate average cost of Autologous Bone Marrow Transplant in Delhi ranges from ₹10 lakh to ₹20 lakh or more.

What Affects the Cost of autologous bmt?

The final cost depends on several factors:

• Diagnosis
• Chemotherapy regimen
• Length of hospital stay
• ICU requirement
• Blood product support
• Infection management
• Medicines and supportive care

Patients should discuss a personalised estimate with their transplant team before treatment.

Why Trust Dr. Satyendra Katewa for Autologous Bone Marrow Transplant in Delhi?

Choosing an experienced transplant specialist is one of the most important decisions during the BMT  transplant journey.

Dr. Satyendra Katewa is among the leading Bone Marrow Transplant and Pediatric Hemato-Oncology specialists in Delhi. With more than 25 years of experience, he has dedicated his career to treating blood cancers, blood disorders, and performing complex bone marrow transplant procedures.

His areas of expertise include:

• Autologous Bone Marrow Transplant
• Allogeneic Bone Marrow Transplant
• Haploidentical Bone Marrow Transplant
• Multiple Myeloma
• Hodgkin Lymphoma
• Non-Hodgkin Lymphoma
• Thalassemia
• Aplastic Anaemia
• Paediatric blood cancers

Patients from Delhi, NCR, and across India consult Dr. Katewa for advanced transplant care, personalised treatment planning, and long-term follow-up.

Final Words

Autologous Bone Marrow Transplant is an established treatment option for multiple myeloma, relapsed Hodgkin lymphoma, Non-Hodgkin lymphoma, and selected high-risk cancers. By using the patient’s own stem cells, the procedure allows doctors to safely administer high-dose chemotherapy while avoiding donor-related complications.

If you are considering a bone marrow transplant and are looking for an experienced BMT specialist in Delhi, consulting a doctor with dedicated expertise in stem cell transplantation can help you make informed treatment decisions. Dr. Satyendra Katewa is among the leading Bone Marrow Transplant specialists in Delhi and provides comprehensive transplant evaluation, personalised treatment planning, and long-term follow-up care at Max Super Speciality Hospital, Patparganj.